Sigachi Industries Limited (SIGACHI.BO)
INR 38.01
(0.16%)
INR 38.01
(0.16%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 579.88 Million INR | -19.13% |
| 2022 | 865.8 Million INR | 40.87% |
| 2021 | 614.6 Million INR | 79.13% |
| 2020 | 343.1 Million INR | 33.6% |
| 2019 | 256.81 Million INR | 23.72% |
| 2018 | 207.57 Million INR | -32.42% |
| 2017 | 307.15 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 192.04 Million INR | 2.75% |
| 2023 Q3 | 354.12 Million INR | 2.76% |
| 2023 Q2 | 344.61 Million INR | 13.76% |
| 2023 Q4 | 186.9 Million INR | -47.22% |
| 2023 Q1 | 302.94 Million INR | 452.6% |
| 2023 FY | 700.15 Million INR | -19.13% |
| 2022 Q4 | 54.82 Million INR | -79.41% |
| 2022 Q3 | 266.23 Million INR | -6.42% |
| 2022 Q2 | 284.49 Million INR | 9.31% |
| 2022 Q1 | 260.26 Million INR | 711.94% |
| 2022 FY | 865.8 Million INR | 40.87% |
| 2021 Q2 | 196.43 Million INR | 27.74% |
| 2021 FY | 614.6 Million INR | 79.13% |
| 2021 Q4 | 32.05 Million INR | -86.2% |
| 2021 Q3 | 232.34 Million INR | 18.28% |
| 2021 Q1 | 153.77 Million INR | 434.32% |
| 2020 FY | 343.1 Million INR | 33.6% |
| 2020 Q3 | 149.16 Million INR | 25.09% |
| 2020 Q2 | 119.24 Million INR | 95.11% |
| 2020 Q1 | 61.11 Million INR | 0.0% |
| 2020 Q4 | -45.99 Million INR | -130.84% |
| 2019 FY | 256.81 Million INR | 23.72% |
| 2018 FY | 207.57 Million INR | -32.42% |
| 2017 FY | 307.15 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bal Pharma Limited | 389.89 Million INR | -48.731% |
| Achyut Healthcare Limited | 1.6 Million INR | -35940.211% |
| Alkem Laboratories Limited | 32.83 Billion INR | 98.234% |
| Divi's Laboratories Limited | 14.17 Billion INR | 95.908% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 99.142% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 95.018% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -1156.363% |
| Mankind Pharma Limited | 23.15 Billion INR | 97.495% |
| Medicamen Biotech Limited | 335.16 Million INR | -73.014% |
| Medico Remedies Limited | 161.84 Million INR | -258.3% |
| Megasoft Limited | 49.52 Million INR | -1070.827% |
| Procter & Gamble Health Limited | 2.99 Billion INR | 80.641% |
| Piramal Pharma Limited | 19.91 Billion INR | 97.088% |
| Sequent Scientific Limited | 2.9 Billion INR | 80.016% |
| Ajanta Pharma Limited | 30.46 Billion INR | 98.096% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.624% |
| Brooks Laboratories Limited | 51.18 Million INR | -1033.034% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | 81.138% |
| Themis Medicare Limited | 782.85 Million INR | 25.927% |
| Unichem Laboratories Limited | 6.72 Billion INR | 91.378% |
| Hester Biosciences Limited | 908.84 Million INR | 36.195% |
| Venus Remedies Limited | 1.91 Billion INR | 69.739% |
| Indoco Remedies Limited | 4.74 Billion INR | 87.789% |
| Ind-Swift Limited | 946.56 Million INR | 38.738% |
| Aarti Drugs Limited | 1.16 Billion INR | 50.33% |
| Alpa Laboratories Limited | 156.14 Million INR | -271.372% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | 77.7% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.395% |
| Granules India Limited | 7.18 Billion INR | 91.926% |
| Gufic Biosciences Limited | 1.07 Billion INR | 46.193% |
| Hikal Limited | 2.48 Billion INR | 76.677% |
| RPG Life Sciences Limited | 1.63 Billion INR | 64.544% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | 58.662% |
| Windlas Biotech Limited | 1 Billion INR | 42.386% |
| ZIM Laboratories Limited | 1.01 Billion INR | 42.759% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | 72.701% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | 47.225% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 95.988% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 98.522% |
| Bajaj HealthCare Limited | 985.34 Million INR | 41.149% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -3477.408% |
| Ipca Laboratories Limited | 13.91 Billion INR | 95.833% |
| Lasa Supergenerics Limited | 291.17 Million INR | -99.155% |
| Laurus Labs Limited | 3.01 Billion INR | 80.74% |
| NATCO Pharma Limited | 10.05 Billion INR | 94.235% |
| Nectar Lifesciences Limited | 625.55 Million INR | 7.3% |
| Shilpa Medicare Limited | 2.18 Billion INR | 73.407% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | 87.338% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 97.293% |
| Wanbury Limited | 1.16 Billion INR | 50.05% |
| Wockhardt Limited | 6.4 Billion INR | 90.939% |
| Strides Pharma Science Limited | 9.16 Billion INR | 93.671% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | 59.141% |
| Suven Life Sciences Limited | 109.75 Million INR | -428.371% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | 47.234% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 96.346% |
| Eris Lifesciences Limited | 4.94 Billion INR | 88.268% |
| Lupin Limited | 95.67 Billion INR | 99.394% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 81.153% |
| Syncom Formulations (India) Limited | 942.39 Million INR | 38.467% |
| Valiant Laboratories Limited | 36.28 Million INR | -1497.969% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 98.657% |
| FDC Limited | 5.34 Billion INR | 89.158% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 93.111% |
| Novartis India Limited | 470.1 Million INR | -23.354% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | 25.022% |
| Neuland Laboratories Limited | 2.92 Billion INR | 80.207% |
| Morepen Laboratories Limited | 1.98 Billion INR | 70.823% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -40.604% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | 14.237% |